03390.HK
Tycoon Group Holdings Limited
HKSE · Healthcare · Medical - Pharmaceuticals · HK
HKD 0.25
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 1.1B | 876.0M | 1.2B | 1.2B |
| Cost of Revenue | 1.5B | 826.6M | 643.4M | 877.5M | 942.7M |
| Gross Profit | 506.3M | 270.0M | 232.7M | 321.1M | 243.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 455.2M | 230.8M | 205.2M | 193.1M | 194.3M |
| General & Admin Expense | 156.9M | 95.5M | 95.3M | 84.5M | 72.9M |
| Selling & Marketing Expense | 200.7M | 135.3M | 109.9M | 108.5M | 121.4M |
| Other Expenses | (5.3M) | (4.3M) | (2.5M) | (208.5M) | 2.4M |
| Total Operating Expenses | 449.8M | 226.5M | 202.7M | (15.4M) | 196.7M |
| Cost and Expenses | 2.0B | 1.1B | 846.0M | 862.1M | 1.1B |
| Operating Income (EBIT) | 56.5M | 43.5M | 30.0M | 336.6M | 64.9M |
| Non-Operating | |||||
| Interest Income | — | 70.0K | 844.0K | 207.0K | 42.0K |
| Interest Expense | 42.9M | 22.0M | 20.5M | 23.4M | 11.3M |
| Net Interest Income | (42.1M) | (22.0M) | (19.6M) | (23.2M) | (11.3M) |
| Other Non-Op Income/Expense | (48.5M) | (26.1M) | (24.5M) | (18.9M) | (14.5M) |
| Non-Operating Income (excl Interest) | 3.5M | 1.6M | 1.9M | 207.1M | 7.0M |
| EBT (Pre-Tax Income) | 8.0M | 17.5M | 5.5M | 317.7M | 50.4M |
| Income Tax Expense | 1.3M | 2.0M | (566.0K) | 20.4M | 6.7M |
| Bottom Line | |||||
| Net Income | 5.0M | 15.7M | 3.2M | 297.3M | 43.8M |
| Earnings from Cont. Ops | 6.7M | 15.5M | 6.0M | 297.3M | 43.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 5.0M | 15.7M | 3.2M | 297.3M | 43.8M |
| Per Share | |||||
| Basic EPS | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.38 | HK$0.06 |
| Diluted EPS | HK$0.00 | HK$0.02 | HK$0.00 | HK$0.38 | HK$0.06 |
| Revenue Per Share | HK$2.34 | HK$1.31 | HK$1.12 | HK$1.53 | HK$1.52 |
| Shares | |||||
| Basic Shares Outstanding | 869.1M | 836.0M | 782.6M | 781.3M | 780.8M |
| Diluted Shares Outstanding | 869.1M | 841.0M | 782.6M | 786.7M | 784.8M |
| Profitability Metrics | |||||
| EBITDA | 82.5M | 55.9M | 35.9M | 356.4M | 82.9M |
| D&A | 29.5M | 14.0M | 7.8M | 19.9M | 18.0M |
| EBIT | 53.0M | 41.9M | 28.1M | 336.6M | 64.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026